Bivalirudin, a peptide anticoagulant, is a direct thrombin inhibitor for anticoagulation in the setting of invasive cardiology, particularly percutaneous coronary intervention.
CAT No: H07005
CAS No:128270-60-0
Synonyms/Alias:Bivalirudin;128270-60-0;Angiomax;Bivalirudin Trifluoroacetate;bivalirudina;bivalirudine;bivalirudinum;BG-8967;Angiox;Hirulog;UNII-TN9BEX005G;L-Leucine, D-phenylalanyl-L-prolyl-L-arginyl-L-prolylglycylglycylglycylglycyl-L-asparaginylglycyl-L-alpha-aspartyl-L-phenylalanyl-L-alpha-glutamyl-L-alpha-glutamyl-L-isoleucyl-L-prolyl-L-alpha-glutamyl-L-alpha-glutamyl-L-tyrosyl-;Bivalirudin TFA;CHEBI:59173;TN9BEX005G;D-Phenylalanyl-L-prolyl-L-arginyl-L-prolylglycylglycylglycylglycyl-L-asparaginylglycyl-L-alpha-aspartyl-L-phenylalanyl-L-alpha-glutamyl-L-alpha-glutamyl-L-isoleucyl-L-prolyl-L-alpha-glutamyl-L-alpha-glutamyl-L-tyrosyl-L-leucine;Bivalirudin trifluoroacetate salt;DTXSID00155847;Bivalirudin;0.9% Sodium Chloride;BG 8967;Angiomax RTU;1191386-55-6;BG8967;Phe-Pro-Arg-Pro-(Gly)4 desulfato-Tyr63'-hirugen;Phe-Pro-Arg-Pro-(Gly)4-desulfohirudin-(53-64);BivalirudinRTU;Bivalirudin [USAN:INN:BAN];Phe-Pro-Arg-Pro-(Gly)4-Asn-Gly-Asp-Phe-Glu-Glu-Ile-Pro-Glu-Glu-Tyr-Leu;HS-2004;BIVALIRUDIN (MART.);SCHEMBL25739;BIVALIRUDIN (USP-RS);Bivalirubin (trifluoroacetate);GTPL6470;DTXCID4078338;B01AE06;EX-A5843;BDBM50248103;MFCD08692016;AKOS015994644;AC-8916;DB00006;FB29604;DA-71564;BIVALIRUDIN IN 0.9% SODIUM CHLORIDE;NS00078779;Q4919218;BRD-K73504359-001-01-3;Bivalirudin trifluoroacetate (H-DL-Phe-DL-Pro-DL-Arg-DL-Pro-Gly-Gly-Gly-Gly-DL-Asn-Gly-DL-Asp-DL-Phe-DL-Glu-DL-Glu-xiIle-DL-Pro-DL-Glu-DL-Glu-DL-Tyr-DL-Leu-OH.TFA);
1. TMEM16F and dynamins control expansive plasma membrane reservoirs
2. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
5. Myotropic activity of allatostatins in tenebrionid beetles
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.